102 related articles for article (PubMed ID: 18800607)
1. [Reevaluation of mechanisms of GVHD and GVL].
Teshima T
Rinsho Ketsueki; 2008 Aug; 49(8):592-7. PubMed ID: 18800607
[No Abstract] [Full Text] [Related]
2. [GVHD and GVL].
Teshima T
Rinsho Ketsueki; 2009 Oct; 50(10):1407-19. PubMed ID: 19915349
[No Abstract] [Full Text] [Related]
3. Graft vs. host disease: pathology, prophylaxis and therapy: GVHD overview.
Weisdorf D
Best Pract Res Clin Haematol; 2008 Jun; 21(2):99-100. PubMed ID: 18503978
[No Abstract] [Full Text] [Related]
4. [Possibility of selective induction of a GVL effect without increasing GVHD].
Akatsuka Y
Rinsho Ketsueki; 2008 Aug; 49(8):607-15. PubMed ID: 18800609
[No Abstract] [Full Text] [Related]
5. [Role of NK cell receptor-expressing cells in the regulation of GVHD and GVL].
Tanaka J
Rinsho Ketsueki; 2008 Aug; 49(8):598-606. PubMed ID: 18800608
[No Abstract] [Full Text] [Related]
6. [GVHD with GVL separation strategy in allogeneic hematopoietic stem cell transplantation].
Huang H; Liu LZ
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2011 Sep; 40(5):461-6. PubMed ID: 21984146
[No Abstract] [Full Text] [Related]
7. [Graft vs. host disease and graft vs. leukemia/tumor effect].
Okamoto S
Nihon Rinsho; 2003 Sep; 61(9):1484-7. PubMed ID: 14515713
[No Abstract] [Full Text] [Related]
8. Administration of short-term immunosuppressive agents after DLI reduces the incidence of DLI-associated acute GVHD without influencing the GVL effect.
Huang XJ; Wang Y; Liu DH; Xu LP; Liu KY; Chen H; Chen YH; Han W; Shi HX
Bone Marrow Transplant; 2009 Sep; 44(5):309-16. PubMed ID: 19234512
[TBL] [Abstract][Full Text] [Related]
9. Immunity and transplantation.
Navarrete CV
Vox Sang; 2004 Jul; 87 Suppl1():39-42. PubMed ID: 15200602
[No Abstract] [Full Text] [Related]
10. Importance of CsA drug monitoring in SCT recipients to minimize GVHD and maximize graft vs. leukemia.
Barkholt L
Pediatr Transplant; 2009 Jun; 13(4):400-3. PubMed ID: 18992059
[No Abstract] [Full Text] [Related]
11. Reduced intensity conditioning for allogeneic hematopoietic stem-cell transplant determines the kinetics of acute graft-versus-host disease.
Turner BE; Kambouris ME; Sinfield L; Lange J; Burns AM; Lourie R; Atkinson K; Hart DN; Munster DJ; Rice AM
Transplantation; 2008 Oct; 86(7):968-76. PubMed ID: 18852664
[TBL] [Abstract][Full Text] [Related]
12. Introduction to graft-versus-host disease.
Ringdén O
Biol Blood Marrow Transplant; 2005 Feb; 11(2 Suppl 2):17-20. PubMed ID: 15682170
[No Abstract] [Full Text] [Related]
13. Donor treatment with a multipegylated G-CSF maximizes graft-versus-leukemia effects.
Banovic T; MacDonald KP; Markey KA; Morris ES; Kuns RD; Varelias A; Hill GR
Biol Blood Marrow Transplant; 2009 Jan; 15(1):126-30. PubMed ID: 19135951
[TBL] [Abstract][Full Text] [Related]
14. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
Kim HJ; Min WS; Cho BS; Eom KS; Kim YJ; Min CK; Lee S; Cho SG; Jin JY; Lee JW; Kim CC
Biol Blood Marrow Transplant; 2009 Jun; 15(6):704-17. PubMed ID: 19450755
[TBL] [Abstract][Full Text] [Related]
15. Role of interleukin-15 in umbilical cord blood transplantation.
Lin SJ; Yan DC; Lee YC; Kuo ML
Int Rev Immunol; 2008; 27(6):518-31. PubMed ID: 19065354
[TBL] [Abstract][Full Text] [Related]
16. Prevention of acute graft-vs-host disease by a single low-dose cyclophosphamide injection following allogeneic bone marrow transplantation.
Prigozhina TB; Elkin G; Khitrin S; Slavin S
Exp Hematol; 2008 Dec; 36(12):1750-9. PubMed ID: 18809241
[TBL] [Abstract][Full Text] [Related]
17. Induction of graft-versus-leukemia (GVL) effect without graft-versus-host disease (GVHD) by pretransplant donor treatment with immunomodulators.
Morecki S; Yacovlev E; Gelfand Y; Shabat Y; Slavin S
Biol Blood Marrow Transplant; 2009 Apr; 15(4):406-15. PubMed ID: 19285627
[TBL] [Abstract][Full Text] [Related]
18. [Graft-versus-host disease: friend or foe?].
Kanda Y
Rinsho Ketsueki; 2008 Aug; 49(8):583-91. PubMed ID: 18800606
[No Abstract] [Full Text] [Related]
19. N-acetylcysteine mildly inhibits the graft-vs.-leukemia effect but not the lymphokine activated cells (LAK) activity.
Weiss L; Reich S; Zeira M; Or R; Resnick IB; Slavin S; Shapira MY
Transpl Immunol; 2007 Apr; 17(3):198-202. PubMed ID: 17331847
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow transplantation: new approaches to immunosuppression and management of acute graft-versus-host disease.
Auletta JJ; Cooke KR
Curr Opin Pediatr; 2009 Feb; 21(1):30-8. PubMed ID: 19242239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
